Atrial Fibrillation: Goals of Therapy and Management Strategies to Achieve the Goals

被引:15
作者
Paclanilam, Benzy. L. [1 ]
Prystowsky, Eric N. [1 ]
机构
[1] Care Grp LLC, Indianapolis, IN 46260 USA
关键词
Atrial fibrillation; Management; Rate control; Rhythm control; Anticoagulation; TACHYCARDIA-INDUCED CARDIOMYOPATHY; LEFT-VENTRICULAR FUNCTION; CORONARY-ARTERY BYPASS; RHYTHM-CONTROL; HEART-FAILURE; CATHETER ABLATION; SINUS RHYTHM; ANTIARRHYTHMIC-DRUGS; ORAL ANTICOAGULATION; STROKE SEVERITY;
D O I
10.1016/j.ccl.2008.09.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The primary goals in the management of patients who have atrial fibrillation are prevention of stroke and tachycardia-induced cardiomyopathy and amelioration of symptoms. Each patient presents to a physician with a specific constellation of symptoms and signs, but, fortunately, most patients can be assigned to broad categories for therapy. For some, anticoagulation and rate control suffice, whereas others require attempts to restore and maintain sinus rhythm. Physicians and patients should be willing to alter therapeutic plans if an initial strategy of rate or rhythm control is unsuccessful.
引用
收藏
页码:189 / +
页数:13
相关论文
共 70 条
[1]   Outpatient treatment of recent-onset atrial fibrillation with the "pill-in-the-pocket'' approach [J].
Alboni, P ;
Botto, GL ;
Baldi, N ;
Luzi, M ;
Russo, V ;
Gianfranchi, L ;
Marchi, P ;
Calzolari, M ;
Solano, A ;
Baroffio, R ;
Gaggioli, G .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (23) :2384-2391
[2]  
[Anonymous], 1989, NEW ENGL J MED, V321, P406
[3]   ROLE OF PROPHYLACTIC ANTICOAGULATION FOR DIRECT-CURRENT CARDIOVERSION IN PATIENTS WITH ATRIAL-FIBRILLATION OR ATRIAL-FLUTTER [J].
ARNOLD, AZ ;
MICK, MJ ;
MAZUREK, RP ;
LOOP, FD ;
TROHMAN, RG .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1992, 19 (04) :851-855
[4]   Impact of atrial fibrillation on the risk of death [J].
Benjamin, EJ ;
Wolf, PA ;
D'Agostino, RB ;
Silbershatz, H ;
Kannel, WB ;
Levy, D .
CIRCULATION, 1998, 98 (10) :946-952
[5]   Rate control in patients with chronic atrial fibrillation [J].
Bjerregaard, P ;
Bailey, WB ;
Robinson, SE .
AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (03) :329-332
[6]   Thoracoscopic extracardiac obliteration of the left atrial appendage for stroke risk reduction in atrial fibrillation [J].
Blackshear, JL ;
Johnson, WD ;
Odell, JA ;
Baker, VS ;
Howard, M ;
Pearce, L ;
Stone, C ;
Packer, DL ;
Schaff, HV .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (07) :1249-1252
[7]   Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation - The Strategies of Treatment of Atrial Fibrillation (STAF) study [J].
Carlsson, J ;
Miketic, S ;
Windeler, J ;
Cuneo, A ;
Haun, S ;
Micus, S ;
Walter, S ;
Tebbe, U .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (10) :1690-1696
[8]   Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial [J].
Connolly, S. ;
Pogue, J. ;
Hart, R. ;
Pfeffer, M. ;
Hohnloser, S. ;
Chrolavicius, S. ;
Yusuf, S. .
LANCET, 2006, 367 (9526) :1903-1912
[9]   Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation [J].
Conway, DSG ;
Pearce, LA ;
Chin, BSP ;
Hart, RG ;
Lip, GYH .
CIRCULATION, 2003, 107 (25) :3141-3145
[10]   Relation between achieved heart rate and outcomes in patients with atrial fibrillation - (from the Atrial Fibrillation Follow-up Investigation of Rhythm Management [AFFIRM] study) [J].
Cooper, HA ;
Bloomfield, DA ;
Bush, DE ;
Katcher, MS ;
Rawlins, M ;
Sacco, JD ;
Chandler, M .
AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (10) :1247-1253